Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples